Clinical Trial

China Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 Diabetes

Recruiting
View on ClinicalTrials.gov →
Summary
The aim of the China Diabetes Type 1 Study (CD1S) is to conduct a nationwide type 1 diabetes (T1D) registry study in patients with T1D and in pediatric adolescent patients with diabetes who had an age of onset \<= 20 years. CD1S compromises a retrospective study enrolling inpatients hospitalized from Jan 1st, 2016 to Dec 31, 2021, and a prospective study beginning from the year 2022.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-08-10.
Trial Details
NCT Number NCT05498974
Lead Sponsor Second Xiangya Hospital of Central South University
Conditions Type1diabetes, Diabetes
Enrollment 20,000 participants
Start Date 2022-01-01
Primary Completion 2035-12-31 (estimated)
Study Completion 2035-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-28